Study Title

Prospective Study Evaluating the Role of Axumin® (Fluciclovine or 18F-FACBC) PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET

Study Details

Description:

The purpose of this prospective cohort study is to investigate the role of Fluciclovine Positron Emission Tomography (PET) in patients with biochemical recurrence of prostate cancer (BCR) and a negative Prostate Specific Membrane Antigen (PSMA) PET, specifically, whether Fluciclovine PET can help detect local recurrence and whether the results of Fluciclovine PET can change management.

Sponsor:

OHSU Knight Cancer Institute

Contacts:

OHSU Diagnostic Radiology Research

radresearch@ohsu.edu

503-494-5157

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468